Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Vornado Realty Trust ( VNO - Analyst Report ) , a leading real estate investment trust (REIT), recently bought a 58.75% interest in Independence Plaza, a 1,328-unit residential complex in Tribeca submarket of Manhattan. The property which comprises 54,500 square feet of retail space and 550 parking spaces is valued at $844.8 million.
As a matter of fact, only last year, Vornado initiated its efforts to get a majority stake in Independence Plaza. It purchased a 51% interest in Independence Plaza’s subordinated debt for $45 million as well as a warrant to buy 25% of the equity for $1 million.
For the recent transaction, Vornado bought 33.75% interest for $160 million from one of the equity partners and exercised its warrant for 25%. Further, the company contributed the appreciated value of its interest in the subordinated debt as preferred equity.
Owing to the deal, Vornado will gain a net amount of $100 million in the fourth quarter, which stems from contributing the debt for preferred equity and exercising its warrant.
The property is burdened by a $329.2 million mortgage. However, in the first quarter of 2013, Vornado and Stellar Management, the other equity partner, plan to refinance the mortgage, significantly reducing their cash investment. The retail space at the property is being managed by Vornado while the residential is being managed by Stellar Management.
New York-based Vornado Realty, acquires, owns and leases office properties, retail space and temperature-controlled logistics and refrigerated warehouses. In addition, the company has investments in other REITs, industrial buildings and Toys ‘R’ Us.
Vornado Realty has a strong asset portfolio in two of the best long-term office markets in the U.S. – New York City and Washington DC. This gives the company a competitive advantage to continually increase rents.
This increase in stake in Independence Plaza further enhances its portfolio and will likely be accretive to its financials going forward. Alongside, it has a healthy balance sheet and adequate liquidity.
Vornado Realty currently has a Zacks #2 Rank that translates into a short-term Buy recommendation. However, one of its competitors, Boston Properties Inc. ( BXP - Analyst Report ) has a Zacks #4 Rank, implying a short-term Sell recommendation.
Read the full Analyst Report on BXP
Read the full Analyst Report on VNO